Sociedad Americana de Hirudoterapia

Iliotibial Band Syndrome (Investigational Adjunct)

Investigational adjunct for chronic iliotibial band syndrome refractory to standard physical therapy and load-management; activity modification, eccentric hip strengthening, and corticosteroid injection remain evidence-based.

Tier C — InvestigationalInvestigacionalLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Resumen para el Paciente

¿Está esto autorizado por FDA para este uso?
Not FDA-cleared for iliotibial band syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
¿Qué evidencia existe?
Tier C (investigational). There are no published controlled trials for ITB syndrome. Most cases resolve within 4 to 12 weeks with structured physical therapy focused on hip-abductor and external-rotator strengthening, gait retraining (cadence, hip-drop correction), foam rolling, activity load management, and - if symptoms persist - a corticosteroid injection at the lateral femoral epicondyle bursa. Imaging is reserved to rule out meniscus or other intra-articular pathology when the diagnosis is unclear.
Riesgos principales
  • Bleeding from each bite site for 6 to 24 hours after the leech detaches
  • Bruising over the lateral thigh for 5 to 10 days
  • Local skin or, rarely, Aeromonas hydrophila infection at the bite site
  • Allergic reaction to leech saliva (uncommon)
  • Delay of evidence-based physical therapy if leech sessions become the primary focus of care
  • Placebo response masking progression of an alternate diagnosis (lateral meniscus tear, lateral collateral ligament pathology)
Quién no debería considerar esto
  • Patients who have not completed at least 8 to 12 weeks of structured physical therapy with a sports-medicine focus
  • Patients with suspected lateral meniscus tear or intra-articular knee pathology pending orthopedic evaluation
  • Patients who received a corticosteroid injection at the site within the past 4 weeks
  • Patients on anticoagulants, with hemophilia, or with severe anemia
  • Patients with active dermatitis or broken skin over the lateral thigh
  • Patients currently in active marathon or peak-load training without a scheduled rest period
Qué preguntar a su clínico
  • Have we confirmed this is ITB syndrome and not lateral meniscus, lateral collateral ligament, or hip pathology?
  • Have I completed a structured physical therapy program with hip abductor and external rotator strengthening?
  • Have we addressed gait factors - cadence, hip drop, footwear, training surfaces, mileage progression?
  • Has a corticosteroid injection been offered, and how does its evidence compare with this investigational option?
  • Where exactly will leeches be placed - confirm placement is lateral to (not directly on) the tender point?
  • What is the practitioner's plan if symptoms do not improve after 2 to 3 sessions?
  • What is the Aeromonas-prevention protocol?
Cuándo buscar atención urgente
  • Sudden inability to bear weight, knee instability, or knee locking (possible meniscal or ligamentous injury)
  • Acute severe lateral knee swelling with warmth (possible septic bursitis)
  • Calf swelling, redness, or warmth (possible DVT)
  • Bleeding from a bite site lasting more than 24 hours
  • Fever, chills, or spreading redness at the bite site
  • Hives, facial or throat swelling, or breathing difficulty

Qué NO significa esto

  • This is not FDA-cleared for ITB syndrome.
  • No published controlled trials exist; mechanistic rationale alone does not establish efficacy.
  • Leech therapy is not a substitute for hip strengthening and gait retraining, which address the underlying biomechanical cause.
  • It does not address intra-articular pathology such as a lateral meniscus tear, which needs orthopedic evaluation.
  • Anecdotal mention in sports-medicine literature is not the same as evidence; placebo response is high in chronic overuse pain.

Clinical Profile

Category
musculoskeletal
ICD-10
M76.30, M76.31, M76.32
Safety tier
low

Evidence Summary

Iliotibial band syndrome is a common overuse injury producing lateral knee or lateral hip pain in runners and cyclists, caused by friction or compression of the distal iliotibial band over the lateral femoral epicondyle. Evidence-based management: activity modification, load reduction, eccentric strengthening of hip abductors and external rotators, foam rolling and soft-tissue mobilization, gait retraining (cadence increase, hip drop correction), and corticosteroid injection at the bursa-like region for refractory cases. Most cases resolve with structured rehabilitation within 4-12 weeks. No published controlled trials of hirudotherapy exist for ITB syndrome. Local placement over the lateral femoral epicondyle or lateral thigh has been mentioned anecdotally in sports-medicine naturopathic literature without controlled evidence.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Lateral meniscus tear or other intra-articular pathology
  • Recent corticosteroid injection at the site (< 4 weeks)
  • Skin abrasion or active dermatitis at lateral thigh
  • Active marathon training without rest-week scheduling

Related Conditions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.

Iliotibial Band Syndrome (Investigational Adjunct) — Hirudotherapy Evidence | ASH